Key result
M-TEER resulted in trivial residual mitral regurgitation and sustained improvement in NYHA functional class from III to I over three years in a CRT non-responder.
Why the study?
Does M-TEER improve symptoms and reduce mitral regurgitation in a CRT non-responder with exercise-induced severe MR?
Case Report (n=1)
No
Does M-TEER improve symptoms and reduce mitral regurgitation in a CRT non-responder with exercise-induced severe MR?
M-TEER can provide sustained symptomatic and echocardiographic benefits in carefully selected CRT non-responders with exercise-induced severe mitral regurgitation.
May offer symptom relief in select CRT non-responders with refractory MR; leaves open efficacy and selection criteria for prospective study.
Mitral valve transcatheter edge-to-edge repair (M-TEER), a minimally invasive procedure that uses a clip to join the mitral valve leaflets, has emerged as an established treatment for severe mitral regurgitation (MR) in drug-refractory heart failure (HF). This case report presents an 80-year-old cardiac resynchronization therapy (CRT) non-responder with a complex cardiac history who underwent successful M-TEER. Despite optimal therapy, including CRT, she experienced recurrent HF symptoms. While resting echocardiography showed mild MR, exercise stress echocardiography (ESE) revealed severe MR. The M-TEER procedure resulted in trivial residual MR and significant symptom improvement. The patient's New York Heart Association (NYHA) functional class improved from III to I, with sustained benefits for three years post procedure. This case highlights the importance of comprehensive MR assessment, including ESE, in complex scenarios. It also underscores the potential long-term benefits of M-TEER in carefully selected CRT non-responders, even with borderline right ventricular function, when supported by thorough multidisciplinary evaluation.
No takes yet. Share an insight, caveat, or question.
Yagasaki et al. (2024) conducted a case report in Exercise-induced severe mitral regurgitation in a CRT non-responder (n=1). Mitral valve transcatheter edge-to-edge repair (M-TEER) was evaluated on NYHA functional class and residual mitral regurgitation. M-TEER resulted in trivial residual mitral regurgitation and sustained improvement in NYHA functional class from III to I over three years in a CRT non-responder.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: